The reviews published in the last three years have only focused on one type of ER, a specific class of compounds, or stage of PCa, or more generally, have covered several types of cancer simultaneously, without exhaustively detailing the effects of estrogens in PCa. The gene discussed is ESR1; the disease is cancer.